• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗凝血酶III活性位点突变导致其肝素依赖性凝血酶和因子Xa抑制活性的解离

Dissociation of heparin-dependent thrombin and factor Xa inhibitory activities of antithrombin-III by mutations in the reactive site.

作者信息

Theunissen H J, Dijkema R, Grootenhuis P D, Swinkels J C, de Poorter T L, Carati P, Visser A

机构信息

Department of Biotechnology and Biochemistry, Organon International bv, Oss, The Netherlands.

出版信息

J Biol Chem. 1993 Apr 25;268(12):9035-40.

PMID:8473344
Abstract

Antithrombin-III (AT-III) is a heparin-dependent inhibitor of thrombin and Factor Xa, two serine proteases that are crucial for blood coagulation. In order to assess whether it would be possible to target AT-III only towards Factor Xa, we replaced parts of the reactive site, or P region, of AT-III by sequences present in prothrombin, a substrate of Factor Xa in the coagulation cascade. We show that replacement of the P3 to P3' region generates the hypothesized phenotype. In fact, point mutation of the P1' site from Ser (present in AT-III) to Ile (present in prothrombin) is sufficient to dissociate heparin-dependent thrombin and Factor Xa inhibitory activities. Interestingly, a combined mutation at P3 and P3' brings about the same dissociation. We show that besides Ile, other amino acids at P1' can lead to the dissociation in inhibitory activity. Amino acids with small side chains (Gly, Ser, Ala, and Thr) have only a marginal effect on the inhibitory activity against either protease. However, larger residues at the P1' position abolish the heparin-dependent anti-thrombin activity, whereas the heparin-dependent anti-Factor Xa activity is not at all or only moderately affected. These results can be rationalized by a comparison of the x-ray structure and a three-dimensional model of the S1' binding pockets of thrombin and Factor Xa, respectively. It appears that the S1' pocket of Factor Xa leaves much more space for the P1' residue of AT-III than the S1' pocket of thrombin.

摘要

抗凝血酶III(AT-III)是一种依赖肝素的凝血酶和Xa因子抑制剂,这两种丝氨酸蛋白酶对血液凝固至关重要。为了评估是否有可能使AT-III仅作用于Xa因子,我们用凝血酶原(凝血级联反应中Xa因子的底物)中存在的序列替换了AT-III反应位点或P区的部分区域。我们发现,替换P3至P3'区域会产生假设的表型。事实上,将P1'位点的丝氨酸(存在于AT-III中)点突变为异亮氨酸(存在于凝血酶原中)足以使肝素依赖的凝血酶和Xa因子抑制活性解离。有趣的是,P3和P3'处的联合突变也会导致同样的解离。我们发现,除了异亮氨酸,P1'处的其他氨基酸也会导致抑制活性的解离。侧链较小的氨基酸(甘氨酸、丝氨酸、丙氨酸和苏氨酸)对两种蛋白酶的抑制活性影响很小。然而,P1'位置较大的残基会消除肝素依赖的抗凝血酶活性,而肝素依赖的抗Xa因子活性则不受影响或仅受到中度影响。通过分别比较凝血酶和Xa因子S1'结合口袋的X射线结构和三维模型,可以解释这些结果。似乎Xa因子的S1'口袋比凝血酶的S1'口袋为AT-III的P1'残基留下了更多空间。

相似文献

1
Dissociation of heparin-dependent thrombin and factor Xa inhibitory activities of antithrombin-III by mutations in the reactive site.抗凝血酶III活性位点突变导致其肝素依赖性凝血酶和因子Xa抑制活性的解离
J Biol Chem. 1993 Apr 25;268(12):9035-40.
2
Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence. Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin.肝素增强抗凝血酶对凝血酶和Xa因子的特异性,且不依赖于反应中心环序列。关于肝素激活的抗凝血酶中Xa因子特异性的别构决定簇的证据。
J Biol Chem. 2001 May 4;276(18):14961-71. doi: 10.1074/jbc.M011550200. Epub 2001 Feb 7.
3
Residues Tyr253 and Glu255 in strand 3 of beta-sheet C of antithrombin are key determinants of an exosite made accessible by heparin activation to promote rapid inhibition of factors Xa and IXa.抗凝血酶β-折叠C的第3条链中的酪氨酸253和谷氨酸255残基是一个外位点的关键决定因素,该外位点通过肝素激活变得可及,以促进对因子Xa和IXa的快速抑制。
J Biol Chem. 2006 May 12;281(19):13424-13432. doi: 10.1074/jbc.M600415200. Epub 2006 Mar 3.
4
The role of the COOH-terminal region of antithrombin III. Evidence that the COOH-terminal region of the inhibitor enhances the reactivity of thrombin and factor Xa with the inhibitor.抗凝血酶III羧基末端区域的作用。有证据表明该抑制剂的羧基末端区域增强了凝血酶和因子Xa与该抑制剂的反应性。
J Biol Chem. 1992 Nov 5;267(31):22224-9.
5
Contribution of lysine 60f to S1' specificity of thrombin.赖氨酸60f对凝血酶S1'特异性的贡献。
Biochemistry. 1997 Feb 4;36(5):1026-33. doi: 10.1021/bi9620823.
6
Conformational conversion of antithrombin to a fully activated substrate of factor Xa without need for heparin.抗凝血酶无需肝素即可构象转化为凝血因子Xa的完全活化底物。
Biochemistry. 1998 Mar 10;37(10):3272-7. doi: 10.1021/bi972182o.
7
Localization of an antithrombin exosite that promotes rapid inhibition of factors Xa and IXa dependent on heparin activation of the serpin.抗凝血酶一个促凝血因子Xa和IXa快速抑制的外位点的定位,该抑制作用依赖于丝氨酸蛋白酶抑制剂的肝素激活。
J Biol Chem. 2003 Dec 19;278(51):51433-40. doi: 10.1074/jbc.M309266200. Epub 2003 Oct 7.
8
Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory properties.蛋白质辅因子对丝氨酸蛋白酶抑制剂特异性的改变。纤连蛋白赋予纤溶酶原激活物抑制剂1凝血酶抑制特性。
J Biol Chem. 1990 Aug 5;265(22):13029-35.
9
Antithrombin-III-Hamilton, Ala 382 to Thr: an antithrombin-III variant that acts as a substrate but not an inhibitor of alpha-thrombin and factor Xa.抗凝血酶III - 汉密尔顿,丙氨酸382突变为苏氨酸:一种抗凝血酶III变体,它作为α-凝血酶和因子Xa的底物而非抑制剂。
Blood. 1991 May 15;77(10):2185-9.
10
Elimination of P1 arginine 393 interaction with underlying glutamic acid 255 partially activates antithrombin III for thrombin inhibition but not factor Xa inhibition.
J Biol Chem. 2002 Jul 5;277(27):24460-5. doi: 10.1074/jbc.M203127200. Epub 2002 Apr 23.

引用本文的文献

1
Durable endothelium-mimicking coating for surface bioengineering cardiovascular stents.用于心血管支架表面生物工程的耐用内皮模拟涂层。
Bioact Mater. 2021 May 24;6(12):4786-4800. doi: 10.1016/j.bioactmat.2021.05.009. eCollection 2021 Dec.
2
Design and characterization of α1-antitrypsin variants for treatment of contact system-driven thromboinflammation.针对接触系统驱动的血栓炎症的 α1-抗胰蛋白酶变体的设计与表征。
Blood. 2019 Nov 7;134(19):1658-1669. doi: 10.1182/blood.2019000481.
3
The extended cleavage specificity of human thrombin.
人凝血酶的扩展裂解特异性。
PLoS One. 2012;7(2):e31756. doi: 10.1371/journal.pone.0031756. Epub 2012 Feb 27.
4
Human mesotrypsin exhibits restricted S1' subsite specificity with a strong preference for small polar side chains.人胰中蛋白酶表现出受限的S1'亚位点特异性,对小极性侧链有强烈偏好。
FEBS J. 2006 Jul;273(13):2942-54. doi: 10.1111/j.1742-4658.2006.05305.x. Epub 2006 Jun 5.
5
Two heads are better than one: crystal structure of the insect derived double domain Kazal inhibitor rhodniin in complex with thrombin.三个臭皮匠,顶个诸葛亮:昆虫源双结构域Kazal抑制剂红猎蝽素与凝血酶复合物的晶体结构
EMBO J. 1995 Nov 1;14(21):5149-57. doi: 10.1002/j.1460-2075.1995.tb00199.x.